Photocure ASA
Develops and commercializes photodynamic technology for bladder cancer.
PHO | OL
Overview
Corporate Details
- ISIN(s):
- NO0010000045
- LEI:
- 5967007LIEEXZXG8OW35
- Country:
- Norway
- Address:
- HOFFSVEIEN 4, 0275 OSLO
- Website:
- https://www.photocure.com/
- Sector:
- Manufacturing
Description
Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-08 07:00 |
Photocure ASA: Results for the third quarter of 2023
|
English | 1.0 MB | ||
| 2023-11-08 07:00 |
Photocure ASA: Results for the third quarter of 2023
|
English | 188.9 KB | ||
| 2023-11-08 07:00 |
Photocure ASA: Results for the third quarter of 2023
|
English | 7.0 KB | ||
| 2023-11-01 07:22 |
Photocure ASA: Invitation to presentation of third quarter 2023 financial resul…
|
English | 2.5 KB | ||
| 2023-10-12 08:32 |
Positive Results for Hexvix Phase III Clinical Trial in China Presented at the …
|
English | 146.8 KB | ||
| 2023-10-12 08:32 |
Positive Results for Hexvix Phase III Clinical Trial in China Presented at the …
|
English | 8.1 KB | ||
| 2023-10-08 13:44 |
Photocure Partner Asieris to present first results for its Hexvix Phase III cli…
|
English | 167.3 KB | ||
| 2023-10-08 13:44 |
Photocure Partner Asieris to present first results for its Hexvix Phase III cli…
|
English | 6.6 KB | ||
| 2023-10-06 13:07 |
New Health Economic analysis in France concludes there is insignificant cost di…
|
English | 172.7 KB | ||
| 2023-10-06 13:07 |
New Health Economic analysis in France concludes there is insignificant cost di…
|
English | 9.7 KB | ||
| 2023-10-02 11:29 |
Major shareholder disclosure in Photocure ASA
|
English | 176.3 KB | ||
| 2023-10-02 11:29 |
Major shareholder disclosure in Photocure ASA
|
English | 289 bytes | ||
| 2023-09-27 16:06 |
Photocure ASA: Change of Board Composition
|
English | 96.9 KB | ||
| 2023-09-27 16:06 |
Photocure ASA: Change of Board Composition
|
English | 1.9 KB | ||
| 2023-09-25 11:59 |
Major shareholder disclosure in Photocure ASA
|
English | 176.4 KB |
Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Photocure ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Photocure ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
